Sabra Healthcare REIT Inc’s recently made public that its Director Cusack Catherine acquired Company’s shares for reported $0.1 million on May 22 ’24. In the deal valued at $14.43 per share,7,000 shares were bought. As a result of this transaction, Cusack Catherine now holds 46,385 shares worth roughly $0.78 million.
Then, FOSTER MICHAEL J sold 10,000 shares, generating $146,830 in total proceeds. Upon selling the shares at $14.68, the Director now owns 63,923 shares.
JMP Securities upgraded its Sabra Healthcare REIT Inc [SBRA] rating to a Mkt outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Mizuho’s analysts, who decreased its forecast for the stock in early December from “an Outperform” to “a Neutral”. Wells Fargo also remained covering SBRA and has increased its forecast on October 01, 2024 with a “an Overweight” recommendation from previously “an Equal weight” rating. Citigroup revised its rating on September 13, 2024. It rated SBRA as “a Buy” which previously was an “a Neutral”.
Price Performance Review of SBRA
On Tuesday, Sabra Healthcare REIT Inc [NASDAQ:SBRA] saw its stock jump 1.02% to $16.80. Over the last five days, the stock has lost -1.41%. Sabra Healthcare REIT Inc shares have fallen nearly -3.00% since the year began. Nevertheless, the stocks have risen 23.17% over the past one year. While a 52-week high of $20.03 was reached on 01/03/25, a 52-week low of $12.83 was recorded on 01/06/25. SMA at 50 days reached $18.13, while 200 days put it at $16.44.
Levels Of Support And Resistance For SBRA Stock
The 24-hour chart illustrates a support level at 16.65, which if violated will result in even more drops to 16.51. On the upside, there is a resistance level at 16.99. A further resistance level may holdings at 17.18. The Relative Strength Index (RSI) on the 14-day chart is 39.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.71%. Stochastics %K at 26.19% indicates the stock is a holding.
How much short interest is there in Sabra Healthcare REIT Inc?
A steep rise in short interest was recorded in Sabra Healthcare REIT Inc stocks on 2024-12-13, growing by 1.51 million shares to a total of 19.47 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 17.96 million shares. There was a rise of 7.77%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 30, 2024 when Deutsche Bank began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
